Grown Rogue International (GRUSF) Return on Invested Capital (2020 - 2026)
Grown Rogue International (GRUSF) posted quarterly Return on Invested Capital of 7588592476.29% for Q1 2026, down 2284957864095.78% quarter-over-quarter from 0.33% in Q4 2023.
Grown Rogue International (GRUSF) Return on Invested Capital (2020 - 2026) Analysis & Trends
Grown Rogue International's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 7588592476.29% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Grown Rogue International | 123.27 Mn | 111.73 Mn | 5.37 Mn | 5,122,882,455.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13,591.14% |
| Mar 31, 2026 | -7,588,592,476.29% |
| Oct 31, 2023 | 0.33% |
| Jul 31, 2023 | 0.18% |
| Apr 30, 2023 | 0.20% |
| Jul 31, 2020 | 0.00% |
| Apr 30, 2020 | -0.01% |
| Jan 31, 2020 | -0.01% |